<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00936481</url>
  </required_header>
  <id_info>
    <org_study_id>090265</org_study_id>
    <nct_id>NCT00936481</nct_id>
  </id_info>
  <brief_title>Study to Assess the Changes in Blood Clotting Factors and Blood Vessel Wall Function in Obstructive Sleep Apnea</brief_title>
  <official_title>Variability of Fibrinolytic Markers and Endothelial Function in Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive sleep apnea is a condition in which people have decreased breathing during their
      sleep. Untreated sleep apnea has been linked to increased risk for cardiovascular diseases.

      This research study is looking at blood clotting factors and blood vessel function in health
      volunteers and patients with newly diagnosed or untreated obstructive sleep apnea to better
      understand the underlying mechanisms for increased cardiovascular risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease (CVD), which includes strokes, has been the number one killer in the
      United States.Each year about 700,000 people experience a new or recurrent stroke, which
      translates into about one stroke every 45 seconds. Apart from traditional risk factors for
      stroke such as hypertension, smoking and atrial fibrillation, obstructive sleep apnea is now
      being increasingly recognized as another important treatable risk factor.

      The majority of strokes and myocardial infarctions are due to atherothrombotic events.
      Impaired fibrinolytic activity increases the propensity for thromboembolic events. Many
      different candidate molecules have been studied as the cause of a hypercoagulable state.
      Plasminogen Activator Inhibitor-1 (PAI-1) is the major physiologic inhibitor of the body's
      fibrinolytic system including the principal serine protease tissue-type plasminogen activator
      (t-PA). It is therefore poised to be a pivotal regulator of the fibrinolytic system.Recent
      studies have shown that PAI-1 levels are elevated in patients with obstructive sleep apnea
      (OSA) and that PAI-1 levels correlate with severity of OSA.

      The purpose of this pilot study is twofold:

        -  To characterize changes in the blood levels of plasminogen activator inhibitor-1 (PAI-1)
           and tissue type plasminogen activator ( t-PA) across the 24 hour cycle in patients with
           obstructive sleep apnea, as compared to normal controls, and to further identify the
           pattern of changes with varying severity of obstructive sleep apnea, and

        -  To study endothelial function in patients with obstructive sleep apnea, as compared to
           normal controls.

      Data gathered from this pilot study will be used to initiate a more comprehensive prospective
      study exploring the link between OSA, endothelial function, the fibrinolytic system and
      cardiovascular events. This area can be further explored by prospectively following patients
      to assess for a reduction in such events with treatment of OSA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Levels of Mean PAI-1 Activity in Patients With Obstructive Sleep Apnea and Controls.</measure>
    <time_frame>at the initial visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of Endothelial (Blood Vessel) Wall Diameter in Patients With Obstructive Sleep Apnea Versus Controls.</measure>
    <time_frame>at initial visit</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">34</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>18 years or older with body mass index between 25-45</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obstructive Sleep Apnea Group</arm_group_label>
    <description>Age 18 years or older with body mass index between 25 and 45</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples to measure plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen
      activator (t-PA)levels, endothelial function,fasting lipid profile and glucose levels.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We are looking for adults over age 18 years without significnt medical or psychiatric
        conditions (other than sleep apnea).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older.

          -  Subjects are able and willing to provide informed consent.

          -  Subjects are willing to cooperate with polysomnography and have serial blood draws
             over a 24-hour period.

          -  Evidence for OSA (AHI&gt;5 events/hour) without treatment or suspected OSA based on
             symptoms in the patient group.

          -  Body mass index of 25-45

        Exclusion Criteria:

          -  History of myocardial infarction, stroke or transient ischemic attack (TIA) or
             peripheral vascular disease.

          -  History of chronic diseases such as diabetes mellitus, uncontrolled hypertension (SBP
             &gt;160, DBP &gt; 120), renal failure on dialysis, cancer, autoimmune or liver disease.

          -  A significant history of medical or psychiatric disease that may impair participation
             in the trial.

          -  Evidence of medical instability (cardiac arrhythmias, congestive heart failure,
             pulmonary disease) that require an expedited evaluation and treatment of the OSA.

          -  History of alcohol, or drug abuse during the one-year-period prior to trial
             participation.

          -  Current use of tobacco products.

          -  Current treatment with angiotensin converting enzyme-inhibitors and or chronic use of
             non-steroidal anti-inflammatory agents.

          -  Another primary sleep disorder that requires intervention with medications or cause
             disrupted sleep.

          -  Patients with unusual sleep or wake habits, including shift work.

          -  Transmeridian travel in the previous 3 months.

          -  Patients with OSA who have already received treatment with CPAP, surgery or oral
             appliance.

          -  Pregnancy; as hormonal changes affect sleep disordered breathing.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kanika Bagai, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center, Nashville, TN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center,Department of Neurology</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005 Nov 10;353(19):2034-41.</citation>
    <PMID>16282178</PMID>
  </reference>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2009</study_first_submitted>
  <study_first_submitted_qc>July 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2009</study_first_posted>
  <results_first_submitted>June 12, 2013</results_first_submitted>
  <results_first_submitted_qc>August 19, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 25, 2013</results_first_posted>
  <last_update_submitted>August 19, 2013</last_update_submitted>
  <last_update_submitted_qc>August 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Kanika Bagai</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>OSA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from the Vanderbilt sleep disorders clinics and from the community using emails and flyers from study start date in 2008- 2012</recruitment_details>
      <pre_assignment_details>Once patients were enrolled in the trial and assigned to the groups, we were able to complete the protocols without having to exclude any participants.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Healthy Controls</title>
          <description>18 years or older with body mass index between 25-45</description>
        </group>
        <group group_id="P2">
          <title>Obstructive Sleep Apnea Group</title>
          <description>Age 18 years or older with body mass index between 25 and 45</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Healthy Controls</title>
          <description>18 years or older with body mass index between 25-45</description>
        </group>
        <group group_id="B2">
          <title>Obstructive Sleep Apnea Group</title>
          <description>Age 18 years or older with body mass index between 25 and 45</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37" spread="11"/>
                    <measurement group_id="B2" value="49" spread="11"/>
                    <measurement group_id="B3" value="43" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comparison of Levels of Mean PAI-1 Activity in Patients With Obstructive Sleep Apnea and Controls.</title>
        <time_frame>at the initial visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Controls</title>
            <description>18 years or older with body mass index between 25-45</description>
          </group>
          <group group_id="O2">
            <title>Obstructive Sleep Apnea Group</title>
            <description>Age 18 years or older with body mass index between 25 and 45</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Levels of Mean PAI-1 Activity in Patients With Obstructive Sleep Apnea and Controls.</title>
          <units>IU/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.2" spread="5.3"/>
                    <measurement group_id="O2" value="23.9" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison of Endothelial (Blood Vessel) Wall Diameter in Patients With Obstructive Sleep Apnea Versus Controls.</title>
        <time_frame>at initial visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Controls</title>
            <description>18 years or older with body mass index between 25-45</description>
          </group>
          <group group_id="O2">
            <title>Obstructive Sleep Apnea Group</title>
            <description>Age 18 years or older with body mass index between 25 and 45</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Endothelial (Blood Vessel) Wall Diameter in Patients With Obstructive Sleep Apnea Versus Controls.</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.43" spread="0.08"/>
                    <measurement group_id="O2" value="0.43" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Healthy Controls</title>
          <description>18 years or older with body mass index between 25-45</description>
        </group>
        <group group_id="E2">
          <title>Obstructive Sleep Apnea Group</title>
          <description>Age 18 years or older with body mass index between 25 and 45</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kanika Bagai, MD, Assistant Professor</name_or_title>
      <organization>Vanderbilt Universit</organization>
      <phone>6153220283</phone>
      <email>kanika.bagai@vanderbilt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

